Spero Therapeutics grants new hire 324,622 stock options, 162,311 RSUs under inducement plan
SPRO•Equity awards granted to new employee
Spero Therapeutics granted 324,622 stock options and 162,311 RSUs to a new employee under its 2019 Inducement Equity Incentive Plan.
- The options vest 25% on Aug. 3, 2027; the remainder vests in 36 equal monthly installments, contingent on continued employment.
- The RSUs vest in four equal annual installments starting Aug. 3, 2027, contingent on continued employment.
